FUSED IMIDAZOLES AS MIDH1 INHIBITORS

The present invention relates to compounds of general formula (I) : in which R1, R2, R3, R4, R6, R7, R8, R9, R10, R11, R12, R13 and X are as defined herein, to methods of preparing said compounds, to intermediate compounds useful for preparing said compounds, to pharmaceutical compositions and combi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: PANKNIN, Olaf, REHWINKEL, Hartmut, ZORN, Ludwig, NGUYEN, Duy, ZIMMERMANN, Katja, HELFRICH, Petra, HARTUNG, Ingo, NEUHAUS, Roland
Format: Patent
Sprache:eng ; fre
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator PANKNIN, Olaf
REHWINKEL, Hartmut
ZORN, Ludwig
NGUYEN, Duy
ZIMMERMANN, Katja
HELFRICH, Petra
HARTUNG, Ingo
NEUHAUS, Roland
description The present invention relates to compounds of general formula (I) : in which R1, R2, R3, R4, R6, R7, R8, R9, R10, R11, R12, R13 and X are as defined herein, to methods of preparing said compounds, to intermediate compounds useful for preparing said compounds, to pharmaceutical compositions and combinations comprising said compounds and to the use of said compounds for manufacturing a pharmaceutical composition for the treatment or prophylaxis of a disease, in particular of neoplasms, as a sole agent or in combination with other active ingredients. La présente invention concerne des composés représentés par la formule générale (I) : dans laquelle , R1, R2, R3, R4, R6, R7, R8, R9, R10, R11, R12, R13 et X sont tels que définis dans l'invention, des procédés de préparation desdits composés, des composés intermédiaires utiles pour préparer lesdits composés, des compositions pharmaceutiques et des combinaisons comprenant lesdits composés, ainsi que l'utilisation desdits composés pour fabriquer une composition pharmaceutique destinée au traitement ou à la prophylaxie d'une maladie, en particulier de néoplasmes, en tant que seul agent ou en combinaison avec d'autres ingrédients actifs.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2017012967A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2017012967A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2017012967A13</originalsourceid><addsrcrecordid>eNrjZFBxCw12dVHw9PV0cYzy93ENVnAMVgByPAwVPP08PJ08Q_yDgnkYWNMSc4pTeaE0N4Oym2uIs4duakF-fGpxQWJyal5qSXy4v5GBobmBoZGlmbmjoTFxqgD39CPL</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>FUSED IMIDAZOLES AS MIDH1 INHIBITORS</title><source>esp@cenet</source><creator>PANKNIN, Olaf ; REHWINKEL, Hartmut ; ZORN, Ludwig ; NGUYEN, Duy ; ZIMMERMANN, Katja ; HELFRICH, Petra ; HARTUNG, Ingo ; NEUHAUS, Roland</creator><creatorcontrib>PANKNIN, Olaf ; REHWINKEL, Hartmut ; ZORN, Ludwig ; NGUYEN, Duy ; ZIMMERMANN, Katja ; HELFRICH, Petra ; HARTUNG, Ingo ; NEUHAUS, Roland</creatorcontrib><description>The present invention relates to compounds of general formula (I) : in which R1, R2, R3, R4, R6, R7, R8, R9, R10, R11, R12, R13 and X are as defined herein, to methods of preparing said compounds, to intermediate compounds useful for preparing said compounds, to pharmaceutical compositions and combinations comprising said compounds and to the use of said compounds for manufacturing a pharmaceutical composition for the treatment or prophylaxis of a disease, in particular of neoplasms, as a sole agent or in combination with other active ingredients. La présente invention concerne des composés représentés par la formule générale (I) : dans laquelle , R1, R2, R3, R4, R6, R7, R8, R9, R10, R11, R12, R13 et X sont tels que définis dans l'invention, des procédés de préparation desdits composés, des composés intermédiaires utiles pour préparer lesdits composés, des compositions pharmaceutiques et des combinaisons comprenant lesdits composés, ainsi que l'utilisation desdits composés pour fabriquer une composition pharmaceutique destinée au traitement ou à la prophylaxie d'une maladie, en particulier de néoplasmes, en tant que seul agent ou en combinaison avec d'autres ingrédients actifs.</description><language>eng ; fre</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2017</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20170126&amp;DB=EPODOC&amp;CC=WO&amp;NR=2017012967A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20170126&amp;DB=EPODOC&amp;CC=WO&amp;NR=2017012967A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>PANKNIN, Olaf</creatorcontrib><creatorcontrib>REHWINKEL, Hartmut</creatorcontrib><creatorcontrib>ZORN, Ludwig</creatorcontrib><creatorcontrib>NGUYEN, Duy</creatorcontrib><creatorcontrib>ZIMMERMANN, Katja</creatorcontrib><creatorcontrib>HELFRICH, Petra</creatorcontrib><creatorcontrib>HARTUNG, Ingo</creatorcontrib><creatorcontrib>NEUHAUS, Roland</creatorcontrib><title>FUSED IMIDAZOLES AS MIDH1 INHIBITORS</title><description>The present invention relates to compounds of general formula (I) : in which R1, R2, R3, R4, R6, R7, R8, R9, R10, R11, R12, R13 and X are as defined herein, to methods of preparing said compounds, to intermediate compounds useful for preparing said compounds, to pharmaceutical compositions and combinations comprising said compounds and to the use of said compounds for manufacturing a pharmaceutical composition for the treatment or prophylaxis of a disease, in particular of neoplasms, as a sole agent or in combination with other active ingredients. La présente invention concerne des composés représentés par la formule générale (I) : dans laquelle , R1, R2, R3, R4, R6, R7, R8, R9, R10, R11, R12, R13 et X sont tels que définis dans l'invention, des procédés de préparation desdits composés, des composés intermédiaires utiles pour préparer lesdits composés, des compositions pharmaceutiques et des combinaisons comprenant lesdits composés, ainsi que l'utilisation desdits composés pour fabriquer une composition pharmaceutique destinée au traitement ou à la prophylaxie d'une maladie, en particulier de néoplasmes, en tant que seul agent ou en combinaison avec d'autres ingrédients actifs.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2017</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZFBxCw12dVHw9PV0cYzy93ENVnAMVgByPAwVPP08PJ08Q_yDgnkYWNMSc4pTeaE0N4Oym2uIs4duakF-fGpxQWJyal5qSXy4v5GBobmBoZGlmbmjoTFxqgD39CPL</recordid><startdate>20170126</startdate><enddate>20170126</enddate><creator>PANKNIN, Olaf</creator><creator>REHWINKEL, Hartmut</creator><creator>ZORN, Ludwig</creator><creator>NGUYEN, Duy</creator><creator>ZIMMERMANN, Katja</creator><creator>HELFRICH, Petra</creator><creator>HARTUNG, Ingo</creator><creator>NEUHAUS, Roland</creator><scope>EVB</scope></search><sort><creationdate>20170126</creationdate><title>FUSED IMIDAZOLES AS MIDH1 INHIBITORS</title><author>PANKNIN, Olaf ; REHWINKEL, Hartmut ; ZORN, Ludwig ; NGUYEN, Duy ; ZIMMERMANN, Katja ; HELFRICH, Petra ; HARTUNG, Ingo ; NEUHAUS, Roland</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2017012967A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2017</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>PANKNIN, Olaf</creatorcontrib><creatorcontrib>REHWINKEL, Hartmut</creatorcontrib><creatorcontrib>ZORN, Ludwig</creatorcontrib><creatorcontrib>NGUYEN, Duy</creatorcontrib><creatorcontrib>ZIMMERMANN, Katja</creatorcontrib><creatorcontrib>HELFRICH, Petra</creatorcontrib><creatorcontrib>HARTUNG, Ingo</creatorcontrib><creatorcontrib>NEUHAUS, Roland</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>PANKNIN, Olaf</au><au>REHWINKEL, Hartmut</au><au>ZORN, Ludwig</au><au>NGUYEN, Duy</au><au>ZIMMERMANN, Katja</au><au>HELFRICH, Petra</au><au>HARTUNG, Ingo</au><au>NEUHAUS, Roland</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>FUSED IMIDAZOLES AS MIDH1 INHIBITORS</title><date>2017-01-26</date><risdate>2017</risdate><abstract>The present invention relates to compounds of general formula (I) : in which R1, R2, R3, R4, R6, R7, R8, R9, R10, R11, R12, R13 and X are as defined herein, to methods of preparing said compounds, to intermediate compounds useful for preparing said compounds, to pharmaceutical compositions and combinations comprising said compounds and to the use of said compounds for manufacturing a pharmaceutical composition for the treatment or prophylaxis of a disease, in particular of neoplasms, as a sole agent or in combination with other active ingredients. La présente invention concerne des composés représentés par la formule générale (I) : dans laquelle , R1, R2, R3, R4, R6, R7, R8, R9, R10, R11, R12, R13 et X sont tels que définis dans l'invention, des procédés de préparation desdits composés, des composés intermédiaires utiles pour préparer lesdits composés, des compositions pharmaceutiques et des combinaisons comprenant lesdits composés, ainsi que l'utilisation desdits composés pour fabriquer une composition pharmaceutique destinée au traitement ou à la prophylaxie d'une maladie, en particulier de néoplasmes, en tant que seul agent ou en combinaison avec d'autres ingrédients actifs.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fre
recordid cdi_epo_espacenet_WO2017012967A1
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title FUSED IMIDAZOLES AS MIDH1 INHIBITORS
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T22%3A01%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=PANKNIN,%20Olaf&rft.date=2017-01-26&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2017012967A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true